IN8bio, Inc. Rings the Closing Bell
ABOUT THIS EVENT
IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative gamma-delta T-cell therapies utilizing its DeltEx platform, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, William Ho, President, CEO, and Co-founder, rings the Closing Bell.